Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10435392 Bipyrazole derivatives as JAK inhibitors

Patent 10435392 was granted and assigned to Incyte on October, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Song Mei0

Jincong Zhuo0

Yun-Long Li0

Ding-Quan Qian0

Date of Patent

October 8, 2019

0

Patent Application Number

158975980

Date Filed

February 15, 2018

0

Patent Citations Received

US Patent 12071439 Process and intermediates for preparing a JAK inhibitor

0

US Patent 11685731 Processes of preparing a JAK1 inhibitor

0

US Patent 11304949 Treatment of hidradenitis suppurativa using JAK inhibitors

US Patent 11833152 JAK1 pathway inhibitors for the treatment of cytokine-related disorders

0

US Patent 11905275 Bipyrazole derivatives as JAK inhibitors

0

US Patent 11905292 Process and intermediates for preparing a JAK inhibitor

0

US Patent 11957661 JAK1 pathway inhibitors for the treatment of vitiligo

0

US Patent 11992490 Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)

0

...

Patent Primary Examiner

0

Patent abstract

The present invention provides compounds of Formula I:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10435392 Bipyrazole derivatives as JAK inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool